CYTEK BIOSCIENCES INC (CTKB:NASDAQ)
$4.51 0.1 (2.2676%)
Analysed CYTEK BIOSCIENCES INC (CTKB:NASDAQ) News Sources
Cytek (CTKB) Q1 2026 Earnings Call Transcript
08-05-2026
fool.com
Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder
20-05-2026
yahoo.com
Promising Penny Stocks To Consider In June 2026
01-06-2026
yahoo.com
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
02-06-2026
yahoo.com
Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
05-06-2026
yahoo.com
Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference
10-06-2026
yahoo.com
Cytek Biosciences (CTKB) Stock Sees Fair Value Falls After Analysts Cut Targets
17-06-2026
yahoo.com
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
15-07-2026
yahoo.com
Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026
22-07-2026
yahoo.com
CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?
23-07-2026
yahoo.com
What is the current price of CYTEK BIOSCIENCES INC (CTKB:NASDAQ)?
The current price of CYTEK BIOSCIENCES INC (CTKB:NASDAQ) is $4.51.
CYTEK BIOSCIENCES INC (CTKB:NASDAQ) absolute price change since previous trading day?
The absolute price change of CYTEK BIOSCIENCES INC (CTKB:NASDAQ) since the previous trading day is $0.1.
CYTEK BIOSCIENCES INC (CTKB:NASDAQ) percentage price change since previous trading day?
The percentage price change of CYTEK BIOSCIENCES INC (CTKB:NASDAQ) since the previous trading day is 2.2676%.
What is the most recent average sentiment score for CYTEK BIOSCIENCES INC (CTKB:NASDAQ)?
The most recent average sentiment score for CYTEK BIOSCIENCES INC (CTKB:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for CYTEK BIOSCIENCES INC (CTKB:NASDAQ)?
The most recent sentiment for CYTEK BIOSCIENCES INC (CTKB:NASDAQ) is .
SEC-8K** Filing Available For CYTEK BIOSCIENCES INC (CTKB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.